The effect of clove oil on the transdermal delivery of ibuprofen in the rabbit by in vitro and in vivo methods

Drug Development and Industrial Pharmacy

Volumn 33, Issue 12, 2007, Pages 1369-1374

  Shen, Qi ^a   Li, Wenji ^a   Li, Wenyan ^b  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b Shanghai Gongli Hospital   (China)

Author keywords

Clove oil; Ibuprofen; Penetration enhancer; Rabbit; Skin permeation enhancement

Indexed keywords

2 METHOXY 4 PROPYLPHENOL; 3 CARENE; ACETYLEUGENOL; CARBOMER; CARYOPHYLLENE OXIDE; CHAVICOL; CINEOLE; CLOVE OIL; EUGENOL; GUAIACOL; HUMULENE; IBUPROFEN; LAUROCAPRAM; PHENOL DERIVATIVE; SANTALOL; UNCLASSIFIED DRUG; VANILLIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; CLOVE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG PENETRATION; IN VITRO STUDY; IN VIVO STUDY; MALE; MASS FRAGMENTOGRAPHY; NONHUMAN; RABBIT; SKIN PERMEABILITY;

ADMINISTRATION, CUTANEOUS; ANIMALS; CLOVE OIL; IBUPROFEN; PERMEABILITY; RABBITS; SKIN; SKIN ABSORPTION;

EID: 37549034306     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.1080/03639040701399346     Document Type: Article

References (25)

1. Barry, B. W. (1983). Dermatological formulations percutaneous absorption. New York: Narcel Dekker.
2. Barry, B. W. (1991). Lipid-protein-partitioning theory of skin penetration enhancement. J. Control. Release, 15, 237-248.
3. Brown, L., & Langer, R. (1998). Transdermal delivery of drugs. Ann. Rev. Med., 39, 221-229.
4. Chen, H., Chang, X., Du, D., Li, J., Xu, H., & Yang X. (2006). Microemulsion-based hydrogel formulation of ibuprofenfor topical delivery. Int. J. Pharm., 315, 52-58.
5. Fang, J., Leu, Y., Hwang, T., & Cheng, H. (2004). Essential oils from sweet basil (Ocimum basilicum) as novel enhancers to accelerate transdermal drug delivery. Biol. Pharm. Bull., 27(11), 1819-1825.
6. Gao, S., & Singh, J. (1998a). In vitro percutaneous absorption enhancement of a lipophilic drug tamoxifen by terpenes. J. Control. Release, 51, 193-199.
7. Gao, S., & Singh, J. (1998b). Effect of oleic acid/ethanol and oleic acid/propylene glycol on the in vitro percutaneous absorption of 5-fluorouracil and tamoxifen and the macroscopic barrier property of porcine epidermis. Int. J. Pharm., 165, 45-55.
8. Godwin, D. A., & Michniak, B. B. (1999). Influence of drug lipophilicity on terpenes as transdermal penetration enhancers. Drug Dev. Ind. Pharm., 25, 905-915.
9. Heard, C. M., Gallagher, S. J., Harwood, J., & Maguire, P. B. (2003). The in vitro delivery of NSAIDs across skin was in proportion to the delivery of essential fatty acids in the vehicle-evidence that solutes permeate skin associated with their solvation cages? Int. J. Pharm., 261, 165-169.
10. Kommuru, T. R., Khan, M. A., Reddy, I. K. (1998). Racemate and enantiomers of ketoprofen: Phase diagram, thermodynamic studies, skin permeability, and use of chiral permeation enhancers. J. Pharm. Sci., 87, 833-840.
11. Kunta, J. R., Goskonda, V. R., & Brotherton, H. O. (1997). Effect of menthol and related terpenes on the percutaneous aborption of propranolol across excised hairless mouse skin. J. Pharm. Sci., 86, 1369-1373.
12. Kydonieus, A. F. (1987). Fundamentals of transdermal drug delivery. In: A. F. Kydonieus, B. Berner, (Eds.), Transdermal delivery of drugs (Volume1, pp. 5-7). Boca Raton, FL: CRC Press.
13. Lu, M. F., Lee, D., & Rao G. S. (1992). Percutaneous absorption enhancement of leuprolide. Pharm. Res., 9(12), 1575-1579.
14. Motlekar, N. A., Srivenugopal, K. S., Wachtel, M. S., & Youan, B.C. (2006) Modulation of gastrointestinal permeability of low-molecular heparin by L-arginine: in-vitro evaluation. J. Pharm. Pharmacol., 58, 591-598.
15. Park, E. S., Chang, S. Y., Hahn, M., Chi, S. C. (2000). Enhancing effect of polyoxyethylene alkyl ethers on the skin permeation of ibuprofen. Int. J.Pharm., 209, 109-119.
16. Roy, S. (1999). Preformulation aspects of transdermal drug delivery systems. In: T. Ghosh, W. Pfister, & S. Yum (Eds.), Transdermal and topical drug delivery systems (pp. 139-166). Interpharm, Buffalo Drove.
17. Scheuplein, R. J. (1978). Skin as barrier. In A. Jarret (Ed.), The physiology and pathophysiology of skin (1693-1730). New York: Academic Press.
18. Stott, P. W., Williams, A. C., & Barry, B. W. (1998). Transdermal delivery from eutectic systems: enhanced permeation of a model drug, ibuprofen. J. Control. Rel., 50, 297-308.
19. Wester, R., & Maibach, H. (1992). Percutaneous absorption of drugs. Clin. Pharmacokinet., 23, 235-266.
20. Williams, A. C., & Barry, B. W. (1991). Terpenes and the lipid-protein-partitioning theory of skin penetration enhancement. Pharm. Res., 8, 17-24.
21. Yamane, M. A., Williams, A. C., & Barry, B. W. (1995). Terpene penetration enhancers in propylene glycol/water co-solvent system: effectiveness and mechanism of action. J. Pharm. Pharmacol., 47, 978-989.
22. Yano, T., Nakagawa, A., Tsuji, M., & Noda, K. (1986). Skin permeability of various non-steroidal anti-inflammatory drugs. Life Sci., 39, 1043-1050.
23. Zhao, K., & Singh, J. (1998). Mechanism of percutaneous absorption of tamoxifen by terpenes: eugenol, D-limonene, and menthone. J, Contr. Release, 55(2-3), 253-260.
24. Zhang, L., Hu, J., Li, L., Gao, L., Zhu, Q., & Su, D. (2006). In vivo and in vitro evaluation of essential oils from Ligusticumchuanxiong HORT on the transdermal delivery of flurbiprofen in rabbits. Biol. Pharm. Bull., 29(6), 1217-1222.
25. Zhang, X., & Liang, W. (1996). Effects of iontophoresis and penetration enhancer on percutaneous of ibuprofen. Modern Applied Pharmacy, 13(3), 18-20.